Oral Disease-Modifying Therapies for Multiple Sclerosis: Are We There Yet? Vijayshree YadavDennis Bourdette Clinical Trial Report 24 June 2010 Pages: 333 - 335
Tarenflurbil in Patients with Mild Alzheimer’s Disease Karen Marder Clinical Trial Report 23 June 2010 Pages: 336 - 337
An Update on the Neurologic Applications of Botulinum Toxins Virgilio Gerald H. EvidenteCharles H. Adler ReviewPaper 22 June 2010 Pages: 338 - 344
What Can We Learn From Freezing of Gait in Parkinson’s Disease? Nina BrownerNir Giladi ReviewPaper 19 June 2010 Pages: 345 - 351
Physical Activity and Mild Cognitive Impairment and Alzheimer’s Disease Nicola T. LautenschlagerKay CoxAlexander F. Kurz ReviewPaper 17 June 2010 Pages: 352 - 358
Hormonal Influences on Cognition and Risk for Alzheimer’s Disease Sarah C. JanickiNicole Schupf ReviewPaper 10 June 2010 Pages: 359 - 366
Minding the Aging Brain: Technology-Enabled Cognitive Training for Healthy Elders Joshua R. Steinerman ReviewPaper 11 June 2010 Pages: 374 - 380
Emerging Oral Therapies in Multiple Sclerosis Devon ConwayJeffrey A. Cohen ReviewPaper 12 June 2010 Pages: 381 - 388
Multiple Sclerosis and Vitamin D: A Review and Recommendations Andrew J. SolomonRuth H. Whitham ReviewPaper 17 June 2010 Pages: 389 - 396
Quality of Life in Multiple Sclerosis: Determinants, Measurement, and Use in Clinical Practice Deborah M. MillerRebecca Allen ReviewPaper 14 July 2010 Pages: 397 - 406
Postural Control in Multiple Sclerosis: Implications for Fall Prevention Michelle H. CameronStephen Lord ReviewPaper 22 June 2010 Pages: 407 - 412